Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1033 (SAR391786)
NCT01720576 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2013-09-12
Summary
This is a study to assess the safety and tolerability of subcutaneously administered REGN1033 (SAR391786) in healthy volunteers.
Conditions
- Healthy Volunteers
Interventions
- DRUG
-
REGN1033 (SAR391786)
- DRUG
Sponsors & Collaborators
- collaborator INDUSTRY
- lead INDUSTRY
Principal Investigators
-
Clinical Trial Management · Regeneron Pharmaceuticals
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2013-06-30
- Completion
- 2013-06-30
Countries
- United States
Study Locations
More Related Trials
-
Safety, Tolerability, and Pharmacokinetics of REGN5069 in Healthy Volunteers
NCT03645746 ·Status: COMPLETED ·Phase: PHASE1
-
Ascending Dose Study of the Safety and Tolerability of REGN727(SAR236553) in Healthy Volunteers
NCT01026597 ·Status: COMPLETED ·Phase: PHASE1
-
A Single-Dose Study of the Safety and Tolerability of REGN475(SAR164877) in Healthy Subjects
NCT00856310 ·Status: COMPLETED ·Phase: PHASE1
-
Ascending Dose Study of the Safety and Tolerability of REGN668(SAR231893) in Normal Healthy Volunteers
NCT01015027 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of SAR231893 (REGN668) in Healthy Japanese Adult Male Subjects
NCT01537653 ·Status: COMPLETED ·Phase: PHASE1
-
Ascending Dose Study of the Safety and Tolerability of REGN6490 in Healthy Volunteers
NCT04616079 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Examine the Safety and Tolerability of Single Ascending Doses of REGN2477
NCT02870400 ·Status: COMPLETED ·Phase: PHASE1
-
An Ascending Single-Dose Study of the Safety, Tolerability and Bioeffect of REGN1193
NCT01933763 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN3918 in Healthy Volunteers
NCT03115996 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Safety and Tolerability of Ascending Single Doses of REGN2009 in Healthy Volunteers
NCT01893528 ·Status: COMPLETED ·Phase: PHASE1
-
Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single and Repeated Doses of SAR444336 in Healthy Adult Participants
NCT05876767 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Learn if Different Doses of REGN7544 Are Safe in Healthy Adult Participants
NCT05970718 ·Status: COMPLETED ·Phase: PHASE1
-
A Single Dose Study Of The Safety And Investigational Product Level Measurement In Healthy Subjects
NCT01284036 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating IMA-026 in Healthy Subjects
NCT00517348 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Single Dose RO6811135 in Healthy Volunteers
NCT01676584 ·Status: COMPLETED ·Phase: PHASE1
-
Repeat Dose Tolerance Study of Regadenoson in Healthy Subjects
NCT01918995 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CC-90006 in Healthy Subjects
NCT02934269 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of SGB-3383 in Healthy Subjects
NCT06995326 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study of SGB-9768 in Adult Healthy Volunteers
NCT06501573 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of FB825 in Healthy Volunteers
NCT02309762 ·Status: COMPLETED ·Phase: PHASE1
-
A First-in-human Single and Repeated Dose Escalation Study of SAR442501 in Healthy Adults Subjects
NCT05846009 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of Single Escalating Doses of BI 1034020 Administered Intravenously or Subcutaneously to Male Healthy Volunteers
NCT01958060 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7049665 in Healthy Volunteers
NCT03221179 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of RG7667 in Healthy Volunteers
NCT01496755 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous and Subcutaneous Single and Repeated Doses of SAR441344 in Healthy Adult Subjects
NCT05845996 ·Status: COMPLETED ·Phase: PHASE1